Cargando…
High levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 might be a biomarker of activity in pediatric patients with MOG-AD
Myelin oligodendrocyte glycoprotein antibody disease (MOG-AD) is characterized by its monophasic or relapsing course and inflammatory demyelinating condition which is unable to be classified in typical multiple sclerosis (MS) or other known neuroinflammatory conditions. In the condition of neuroinfl...
Autores principales: | Zhou, Anna, Zhang, Weihua, Ren, Changhong, Zhou, Ji, Chang, Haoxiao, Ren, Xiaotun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609779/ https://www.ncbi.nlm.nih.gov/pubmed/36313865 http://dx.doi.org/10.3389/fped.2022.908527 |
Ejemplares similares
-
Immunotherapies for Anti-N-M-methyl-D-aspartate Receptor Encephalitis: Multicenter Retrospective Pediatric Cohort Study in China
por: Guang, Shiqi, et al.
Publicado: (2021) -
Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, Samuel, et al.
Publicado: (2022) -
Diagnostic Value of Endotracheal Tube-Aspirate Soluble Triggering Receptor Expressed on Myeloid Cells-1 Concentration for Neonatal Ventilator-Associated Pneumonia
por: Zhou, Jian, et al.
Publicado: (2021) -
Quantitative proteomics on the cerebrospinal fluid of hydrocephalus in neonatal bacterial meningitis
por: Chen, Juncao, et al.
Publicado: (2022) -
Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease
por: Mo, Mingshu, et al.
Publicado: (2021)